Troll Busters LLC Files for Reexamination of United States Patent 5,582,989 Exclusively Licensed to Abbott Laboratories

MERCER ISLAND, Wash.--(BUSINESS WIRE)--Troll Busters LLC of Mercer Island, WA announces that it has filed yesterday a Reexamination Brief with the United States Patent and Trademark Office for a reexamination of all of the broad multiplex PCR method claims of U.S. Patent 5,582,989 (‘989 Patent) entitled “Multiplex Genomic DNA Amplification for Deletion Detection.” This patent was originally filed by Baylor College of Medicine and then exclusively licensed to Abbott Laboratories (NYSE: ABT).

MORE ON THIS TOPIC